REQUEST A DEMO
Total
USD $0.00
Search more companies

Unitpharma Supplies Sdn. Bhd. (Malaysia)

Main Activities: Veterinary Services
Full name: Unitpharma Supplies Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Unitpharma Supplies Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Petaling Jaya. The enterprise operates in the Veterinary Services industry. The enterprise was incorporated on September 24, 2003. From the latest financial highlights, Unitpharma Supplies Sdn. Bhd. reported a net sales revenue increase of 33.33% in 2022. Its total assets grew by 1.47% over the same period. The net profit margin of Unitpharma Supplies Sdn. Bhd. decreased by 2.39% in 2022.

Headquarters
21G Jalan Pjs 10/4, Subang Indah
Petaling Jaya; Selangor; Postal Code: 46000

Contact Details: Purchase the Unitpharma Supplies Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Unitpharma Supplies Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Unitpharma Supplies Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Unitpharma Supplies Sdn. Bhd. report to view the information.
Incorporation Date:
September 24, 2003
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
96%
Purchase this report to view the information.
4%
Company Performance
Financial values in the chart are available after Unitpharma Supplies Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
33.33%
Total operating revenue
33.33%
Operating profit (EBIT)
-11.34%
EBITDA
-3.03%
Net Profit (Loss) for the Period
-16.59%
Total assets
1.47%
Total equity
9%
Operating Profit Margin (ROS)
-2.71%
Net Profit Margin
-2.39%
Return on Equity (ROE)
-2.53%
Debt to Equity Ratio
-13.14%
Quick Ratio
-0.01%
Cash Ratio
-0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?